Novartis AG (NVS)

USD 114.29

(2.66%)

Inventory Summary of Novartis AG

  • Novartis AG's latest annual inventory in 2023 was 5.91 Billion USD , down -17.59% from previous year.
  • Novartis AG's latest quarterly inventory in 2024 Q3 was 5.93 Billion USD , up 3.34% from previous quarter.
  • Novartis AG reported annual inventory of 7.17 Billion USD in 2022, up 7.64% from previous year.
  • Novartis AG reported annual inventory of 6.66 Billion USD in 2021, down -6.52% from previous year.
  • Novartis AG reported quarterly inventory of 5.93 Billion USD for 2024 Q3, up 3.34% from previous quarter.
  • Novartis AG reported quarterly inventory of 5.74 Billion USD for 2024 Q1, down -2.88% from previous quarter.

Annual Inventory Chart of Novartis AG (2023 - 1998)

Historical Annual Inventory of Novartis AG (2023 - 1998)

Year Inventory Inventory Growth
2023 5.91 Billion USD -17.59%
2022 7.17 Billion USD 7.64%
2021 6.66 Billion USD -6.52%
2020 7.13 Billion USD 19.21%
2019 5.98 Billion USD -14.0%
2018 6.95 Billion USD 1.3%
2017 6.86 Billion USD 9.78%
2016 6.25 Billion USD 0.47%
2015 6.22 Billion USD 2.18%
2014 6.09 Billion USD -16.16%
2013 7.26 Billion USD 7.76%
2012 6.74 Billion USD 13.73%
2011 5.93 Billion USD -2.68%
2010 6.09 Billion USD 4.51%
2009 5.83 Billion USD 0.66%
2008 5.79 Billion USD 6.18%
2007 5.45 Billion USD 21.28%
2006 4.49 Billion USD 20.75%
2005 3.72 Billion USD 4.69%
2004 3.55 Billion USD 6.34%
2003 3.34 Billion USD 12.62%
2002 2.97 Billion USD 19.7%
2001 2.48 Billion USD -1.23%
2000 2.51 Billion USD -41.98%
1999 4.33 Billion USD -10.99%
1998 4.86 Billion USD 0.0%

Peer Inventory Comparison of Novartis AG

Name Inventory Inventory Difference
AbbVie Inc. 4.09 Billion USD -44.255%
Bristol-Myers Squibb Company 2.66 Billion USD -122.126%
Bristol-Myers Squibb Company Ce 2.66 Billion USD -122.126%
Johnson & Johnson 11.18 Billion USD 47.116%
Eli Lilly and Company 5.77 Billion USD -2.429%
Merck & Co., Inc. 6.35 Billion USD 6.999%
Organon & Co. 1.31 Billion USD -349.658%
Pfizer Inc. 10.18 Billion USD 41.967%